Solares, Carmen http://orcid.org/0000-0001-6656-8836
Garcia-Argibay, Miguel
Chang, Zheng
Dobrosavljevic, Maja
Larsson, Henrik
Andershed, Henrik
Funding for this research was provided by:
European Union’s Horizon the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement (754285)
Örebro University
Article History
Received: 1 July 2022
Accepted: 27 January 2023
First Online: 2 February 2023
Competing interests
: Henrik Larsson reports receiving grants from Shire Pharmaceuticals; personal fees from and serving as a speaker for Medice, Shire/Takeda Pharmaceuticals and Evolan Pharma AB; and sponsorship for a conference on attention-deficit/hyperactivity disorder from Shire/Takeda Pharmaceuticals and Evolan Pharma AB, all outside the submitted work. All other authors have no competing interests.